SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE
7 references·0 citing·26 second hop
Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE (2018)Cost-effective interventions for breast c…Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions (2017)Disease control programme sup…The cost and burden of cancer in the European Union 1995–2014 (2016)The cost and burden of cancer…Economic burden of cancer across the European Union: a population-based cost analysis (2013)Economic burden of cancer acr…Methods to assess the costs and health effects of interventions for improving health in developing countries (2005)Methods to assess the costs a…Making choices in health: who guide to cost-effectiveness analysis (2004)Making choices in health: who…Generalized cost-effectiveness analysis for national-level priority-setting in the health sector (2003)Generalized cost-effectivenes…Generalised cost-effectiveness analysis: an aid to decision making in health. (2002)Generalised cost-effectivenes…Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Cost-Effectiveness in Health and Medicine (1996)Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? (2007)Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study (2012)Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study (2012)Methods for the Economic Evaluation of Health Care Programmes (2005)A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (2015)Economic Burden of Bladder Cancer Across the European Union (2015)Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050 (2023)A framework for assessing the performance of health systems. (2000)Cost-Effectiveness Thresholds: the Past, the Present and the Future (2018)Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies (2018)Eliciting and Utilizing Willingness to Pay: Evidence from Field Trials in Northern Ghana (2019)Cost-of-Illness Methodology: A Guide to Current Practices and Procedures (1982)Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Out-of-pocket-payments and the financial burden of 502 cancer patients of working age in Germany: results from a longitudinal study (2018)Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries (2019)Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries (2022)Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations (1991)Programme costs in the economic evaluation of health interventions (2003)Costs of scaling up health interventions: a systematic review (2005)Accounting for the cost of scaling‐up health interventions (2004)Clarifying Efficiency-Equity Tradeoffs Through Explicit Criteria, With a Focus on Developing Countries (2005)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)Health outcomes in economic evaluation: the QALY and utilities (2010)
this work references cited by second hop

References

  • 2004Making choices in health: who guide to cost-effectiveness analysis1,259 cited
  • 2013Economic burden of cancer across the European Union: a population-based cost analysis1,009 cited
  • 2003Generalized cost-effectiveness analysis for national-level priority-setting in the health sector535 cited
  • 2005Methods to assess the costs and health effects of interventions for improving health in developing countries142 cited
  • 2016The cost and burden of cancer in the European Union 1995–2014115 cited
  • 2002Generalised cost-effectiveness analysis: an aid to decision making in health.85 cited
  • 2017Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions52 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work